|
EORTC AISBL / IVZW |
The General Assembly of the EORTC is comprised of effective members (voting and non-voting).
Acting President: |
M. Piccart, Brussels (BE) |
Past Presidents (last three): |
A.M.M. Eggermont, Rotterdam (NL) |
A.T. van Oosterom, Leuven (BE) |
|
J.-C. Horiot, Dijon (FR) |
Brain Tumour Group |
M. J. van den Bent, Rotterdam (NL) |
Breast Cancer Group |
H. Bonnefoi, Bordeaux (FR) |
Children's Leukemia Group |
Y. Bertrand, Lyon (FR) |
Gastrointestinal Tract Cancer Group |
M. Lutz, Saarbrücken (DE) |
Genito-Urinary Cancer Group |
T. de Reijke, Amsterdam (NL) |
Gynecological Cancer Group |
N. Reed, Glasgow (GB) |
Head and Neck Cancer Group |
J. Vermorken, Antwerp (BE) |
Infectious Diseases Group |
J. Maertens, Leuven (BE) |
Leukemia Group |
T. de Witte, Nijmegen (NL) |
Lung Cancer Group |
P. Baas, Amsterdam (NL) |
Lymphoma Group |
R.W.M. Van Der Maazen, Nijmegen (NL) |
Melanoma Group |
A. Spatz,Villejuif (FR) |
Pathobiology Group |
M. Schmitt, Munich (DE) |
Pharmacology and Molecular Mechanisms |
N. Zaffaroni, Milan (IT) |
Quality of Life Group |
N. Aaronson, Amsterdam (NL) |
Radiation Oncology Group |
K. Haustermans, Leuven (BE) |
Soft Tissue and Bone Sarcoma Group |
J.Y. Blay, Lyon (FR) |
Cancer in the Elderly |
U. Wedding, Jena (DE) |
|
Cutaneous Lymphoma |
S. Whittaker, London (GB) |
Clinical Research Division |
R. Stupp, Lausanne (CH) |
Laboratory Research Division |
F. Sweep, Nijmegen (NL) |
Independent Data Monitoring Committee |
R. Kaplan, Leeds (GB) |
Membership Committee |
A.T. van Oosterom, Leuven (BE) |
New Drug Advisory Committee |
D. Cameron, Leeds (GB) |
Protocol Review Committee |
O. S. Nielsen, Aarhus (DK) |
Translational Research Advisory Committee |
F. Sweep, Nijmegen (NL) |
Quality Assurance Committee |
T. de Witte, Nijmegen (NL) |
Scientific Audit Committee |
J.-C. Horiot, Dijon (FR) |
University Medical Center,
Nijmegen (NL) |
T. de Witte |
UZ Leuven,
Leuven (BE) |
P. Schöffski |
Arnhems Radiotherapeutisch Instituut, Arnhem /Harderwijk (NL) |
R. Keus |
UZ Rotterdam,
Rotterdam (NL) |
R. de Wit |
Maria Sklodowska - Curie Cancer Center, Warsaw (PL) |
W. Ruka |
Hopitaux Universitaires Bordet-Erasme, Brussels (BE) |
A. Awada |
The Netherlands Cancer Institute,
Amsterdam (NL) |
E. Rutgers |
Institut Gustave Roussy,
Villejuif (FR) |
G. Vassal |
Leiden University Medical Centre,
Leiden (BE) |
C. van de Velde |
Academisch Medisch Centrum,
Amsterdam( NL) |
G. van Tienhoven |
Institut Bergonie,
Bordeaux (FR) |
L. Mauriac |
Universiteit Gent,
Gent (BE) |
J. van Meerbeeck |
|
Western Infirmary,
Glasgow (GB) |
N. Reed |
Charité,
Berlin (DE) |
V. Budach |
St. James' University Hospital, Leeds (GB) |
A. Kiltie |
Board Members (GA Effective Non Voting Members)
Vice-President |
T. Tursz, Villejuif (FR) |
Secretary General |
P.Schöffski, Leuven (BE) |
| Treasurer |
C. Sternberg, Roma (IT) |
| Member | M. Aapro, Genolier (CH) |
| Member | T. Cufer, Ljubljana (SI) |
| Member |
P. Hohenberger, Mannheim (DE) |
| Member |
J. Jassem, Gdanks (PL) |
Member |
I. Judson, London (GB) |
| Member | A. Spatz, Villejuif (FR) |
Member |
H. van Poppel, Leuven (BE) |
Other Effective (GA Non Voting Members)
Director General, EORTC |
F. Meunier, Brussels (BE) |
Chairman, The EORTC Charitable Trust |
Sir Christopher Mallaby, London (GB) |
Editor-in-Chief, European Journal of Cancer |
J.F. Smyth, Edinburgh (GB) |
OECI President |
U. Ringborg, Stockholm (SE) |
| EJC Liaison Officer |
J-C. Horiot, Dijon (FR) |
Executive Secretary, The EORTC Charitable Trust |
V. Agnew, London (GB) |
European Programmes Manager, US-NCI Liaison Office |
S. Radtke, Brussels (BE) |
Past Presidents
L. Denis (BE) |
S. Garattini (IT) |
G. Mathe (FR) |
J. G. Mc Vie (GB) |
D. van Bekkum (NL) |
| U. Veronesi (IT) |